In line with these findings, seeding experiments with SarkoSpin brain extracts derived from AD patients with Tau/TDP-43 co-pathology reveal a reduced Tau seeding capacity compared to extracts from AD patients with Tau-only pathology, supporting the notion that presence of TDP-43 reduces Tau seeding. Here, MAPT is linked to Alzheimer disease.